1.

Misuse of anticoagulants in COVID-19 patient: A case of gastrointestinal bleeding

Pages 1-2
Reham Soliman; Gamal Shiha
2.

Coagulopathy in COVID-19 from Pathogenesis until Treatment: A systemic Review

Pages 3-8
Nasser Mousa; Ahmed Abdel-Razik; Eman Mousa; Tasnim Elbadrawy; Khaled Hosni; Aya Mousa; Ahmed Taha; Alaa Elmetwalli
3.

Serum Thioredoxin as a Diagnostic Marker for Hepatocellular Carcinoma in Cirrhotic Hepatitis C Patients

Pages 9-15
Tarek Sheta; Mahmoud Selim; Mohammed Sabry; Ahmed Saed
4.

Macrophage Inflammatory Protein Type 1 Beta as a Novel Diagnostic Marker for Diagnosis of Spontaneous Bacterial Peritonitis

Pages 16-20
Alaa N Mahmoud; Sahar El-gharabawy; Rania Elhelaly; Maha R. Habeeb
5.

Impact of Direct-Acting Antiviral Agents Treatment on Body Mass Index and Lipid Profile in Egyptian Chronic Hepatitis C Patients

Pages 21-26
Ayman Menesy; Ahmed Ehab; Neven Abbas
6.

Screening of Occult Hepatitis B Virus Infection among Egyptian Blood Donors.

Pages 27-31
Attia Ahmed Attia; Alaa Elmetwalli
7.

Assessment of Patient Compliance during treatment of chronic hepatitis C infection using Sofosbuvir and Daclatasvir with or without Ribavirin.

Pages 32-39
Sarah Ali; Farag Mohamed; Maha R Habeeb